Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07638150 · ClinicalTrials.gov registry record · NA

PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)

A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Not yet
Registry status
NA
Development phase
20
Enrollment target

NCT07638150: Clinical Trial NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT07638150 is a NA study that has not yet begun recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07638150, a NA study, has not yet begun recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NOT YET RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.

Primary Outcome

Percentage of eligible participants who enroll.

Interventions

  • OTHER Mediterranean Diet

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-08
Est. Completion 2027-04
Phase NA

What is known before NCT07638150 opens enrollment

NCT07638150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Mediterranean Diet is the first listed.

NCT07638150 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07638150 about?

NCT07638150 is a clinical study titled "PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)". This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims includ...

What is the current status of trial NCT07638150?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08. Estimated completion is 2027-04.

What interventions are being tested in trial NCT07638150?

The interventions under investigation include: Mediterranean Diet (OTHER).

Who is sponsoring clinical trial NCT07638150?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07638150's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07638150, the US trial registry maintained by the National Library of Medicine. NCT07638150 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.